0001209191-18-039524.txt : 20180626
0001209191-18-039524.hdr.sgml : 20180626
20180626171857
ACCESSION NUMBER: 0001209191-18-039524
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180622
FILED AS OF DATE: 20180626
DATE AS OF CHANGE: 20180626
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SMITH IAN F
CENTRAL INDEX KEY: 0001197032
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 18920064
MAIL ADDRESS:
STREET 1: C/O ACORDA THERAPEUTICS, INC.
STREET 2: 420 SAW MILL RIVER ROAD
CITY: ARDSLEY
STATE: NY
ZIP: 10502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-06-22
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197032
SMITH IAN F
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, COO
Common Stock
2018-06-22
4
M
0
4250
109.14
A
50949
D
Common Stock
2018-06-22
4
S
0
4250
160.00
D
46699
D
Common Stock
5306
I
401(k)
Stock Option (Right to Buy)
109.14
2018-06-22
4
M
0
4250
0.00
D
2025-02-02
Common Stock
4250
12750
D
Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1.
The option vests in 16 quarterly installments from 02/03/2015.
/s/ Stephen Migausky, Attorney-In-Fact
2018-06-26